Abiomed
ABMD
#1079
Rank
$17.18 B
Marketcap
$381.02
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Operating Margin for Abiomed (ABMD)

Operating Margin as of March 2024 (TTM): 31.76%

According to Abiomed's latest financial reports and stock price the company's current Operating Margin is 31.76%. At the end of 2022 the company had an Operating Margin of 18.47%.

Operating Margin history for Abiomed from 2013 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202218.47%-45.69%
202134.01%11.35%
202030.54%-10.77%
201934.23%26.67%
201827.02%31.73%
201720.51%2.67%
201619.98%59.96%
201512.49%168.89%
20144.64%-56.44%
201310.66%429.94%
20122.01%-118.74%
2011-10.74%-49.84%
2010-21.41%-49.18%
2009-42.13%-38.54%
2008-68.55%26.68%
2007-54.11%-18.78%
2006-66.62%682.65%
2005-8.51%-78.63%
2004-39.83%-52.37%
2003-83.62%-8.79%
2002-91.67%29.96%
2001-70.54%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
11.27%-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
15.97%-49.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-13.98%-144.02%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.